Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0038454 (
stroke
)
147,016
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Focal cerebral ischaemia was induced in rats by occlusion of the left middle cerebral artery. Two days later, infarct volume was determined by magnetic resonance imaging and the concentrations of the polyamines putrescine (PU), spermine and spermidine by HPLC. In control (occluded) animals, PU levels were elevated in infarcted and non-infarcted areas of the left hemisphere. Treatment with the
ornithine decarboxylase
(
ODC
) inhibitor alpha-difluoromethylornithine, prevented the ischaemia-induced increase in tissue PU without affecting infarct volume. Conversely, administration of the N-methyl-D-aspartate (NMDA) receptor antagonist CGP 40116 decreased cortical infarction without changing the tissue content of PU. We conclude that there is no direct link between NMDA receptor activation and brain PU, or PU and post-ischaemic tissue damage, and that inhibitors of
ODC
are not cerebroprotective in this animal model of
stroke
.
...
PMID:Differing effects of alpha-difluoromethylornithine and CGP 40116 on polyamine levels and infarct volume in a rat model of focal cerebral ischaemia. 135 66
After a chloroform intraperitoneal injection, lactate dehydrogenase, alanine aminotransferase and particularly aspartate aminotransferase serum activities are much more raised in deficient animals. Liver
ornithine decarboxylase
(
ODC
) activity normally decreases in rats between the 4th. and the 7th. month after the weaning. In vitamin A deficient animals, basal values of the enzyme activity are lower and the decrease is deeper. But even at month 7, liver sustains a partial capacity of
ODC
recovery if retinol is fed during 15 days. Chloroform administration strongly enhances liver
ODC
activity in normal rats. In the deficiency, stimulation is lower in absolute value but relatively higher if referred to basal level. After retinol refeeding, chloroform stimulates enzyme activity to nearly normal values. Vitamin A deficiency impairs obviously liver
ODC
activity and its response to chloroform stimulation in rats, but the
stroke
is at least partially reversible in our conditions. Moreover, deficient animals maintain a non negligible capacity of
ODC
response under chloroform stimulation.
...
PMID:[Toxicity of chloroform and vitamin A status in the rat]. 145 50
We studied the time course and molecular mechanisms of changes in brain polyamines and their rate-regulatory synthetic enzyme
ornithine decarboxylase
during reversible forebrain ischemia and recirculation in the gerbil. Bilateral carotid occlusion induced an acute (less than 2 minutes), transient increase in
ornithine decarboxylase
activity and putrescine level. After 15 minutes of ischemia, recirculation evoked an immediate (less than 1 minute) increase in
ornithine decarboxylase
activity and putrescine concentration that progressed over a 15-minute period. A small rise in spermidine and spermine also was observed. A secondary increase in
ornithine decarboxylase
activity and the levels of putrescine and spermidine commenced after 6 hours of recirculation. Pretreatment with a-difluoromethylornithine, a specific suicide inhibitor of
ornithine decarboxylase
, or MK-801, a noncompetitive N-methyl-D-aspartate receptor antagonist, abolished all early and delayed increases in
ornithine decarboxylase
activity and polyamine levels. This is the first demonstration that both ischemia and postischemic recirculation evoke rapid, transient increases in the activity of
ornithine decarboxylase
and the levels of polyamines, most notably the
ornithine decarboxylase
product, putrescine. Our results indicate that N-methyl-D-aspartate receptor activation (by an ischemically induced elevation of extracellular glutamate) is responsible for initiating the early and the delayed stimulation of
ornithine decarboxylase
activity.
Ornithine decarboxylase
activation causes the rapid rise in the levels of putrescine and higher polyamines observed in the acute response to ischemia and the acute and delayed response to postischemic recirculation. These polyamine changes may be involved in the pathophysiology of Ca2+ entry and neuronal death after brain ischemia.
Stroke
1990 Nov
PMID:Brain polyamines are controlled by N-methyl-D-aspartate receptors during ischemia and recirculation. 214 83
An increase in the activity of the enzyme
ornithine decarboxylase
has been shown to be associated with ischemia and other lesions of the nervous system. We have previously characterized the induction of
ornithine decarboxylase
in cerebral cortex following excitotoxin lesion of the nucleus basalis and have shown it to be sensitive to treatment with MK-801 up to 4 hours after the lesion and to be associated with an early increase in
ornithine decarboxylase
mRNA. In this study, we have used this model to investigate the effect of dihydropyridines on this response to lesion. Injection of 1 micrograms kainate into the nucleus basalis causes a large increase in
ornithine decarboxylase
activity that is maximal at 8 hours (292 pmol/mg/hr) when there is a 200-fold increase in
ornithine decarboxylase
activity compared with unoperated control animals (1.4 pmol/mg/hr). Treatment of animals with nimodipine either 5 minutes before or 60 minutes after lesion did not affect the maximal
ornithine decarboxylase
response at 8 hours. However, repeated injections (four of nimodipine, 10 mg/kg) significantly (p less than 0.001) attenuated the response to lesion by 75%. Injections were given 5 minutes before lesion and at 1.0, 3.5, and 6.0 hours after lesion. The efficacy of this treatment regimen indicated that maintaining a blockade of dihydropyridine-sensitive channels over this period was necessary to attenuate this induction of
ornithine decarboxylase
. To investigate the critical period over which dihydropyridines might be effective, their action at the earlier time point of 4 hours was tested where a significant induction of
ornithine decarboxylase
occurs (60 pmol/mg/hr).(ABSTRACT TRUNCATED AT 250 WORDS)
Stroke
1990 Dec
PMID:Reversal of neurotoxin-induced ornithine decarboxylase activity in rat cerebral cortex by nimodipine. A potential neuroprotective mechanism. 226 Jan 56
This study examines the pathophysiology of
stroke
secondary to focal cerebral ischemia. The interaction of arachidonic acid metabolites and polyamines, a class of ubiquitous ornithine-derived molecules with important membrane effects on edema, Ca++-dependent endocytosis, platelet function, and prostaglandin (PG) formation, are correlated with regional changes in H2 clearance, cerebral blood flow (rCBF), ischemic edema, and somatosensory evoked responses (SSERs) after middle cerebral artery (MCA) occlusion. Thirty cats were studied up to 3 hours before and 6 hours after right MCA occlusion. Four areas of brain showing different levels of perfusion after MCA occlusion were sampled for tissue levels of PGs: 6-keto-PGF1 alpha, PGE2, and as well as thromboxane B2 (TXB2),
ornithine decarboxylase
activity (ODC) (a measure of polyamine activity) and gravimetric determination of cerebral edema. After right MCA occlusion, right hemisphere SSER amplitude decreased and interpeak latency increased markedly. rCBF was distributed into zones of dense, partial, and no ischemia ranging from 12.6 to 59.4 ml/100 g/minute. Ischemic edema was distributed inversely to rCBF and was increased in areas of dense ischemia (85.2 +/- 0.5%) and ischemia (82.7 +/- 0.7%), but not in partially ischemic or control areas. 6-Keto-PGF1 alpha (1257.3 pg/mg), PGE2 (1628.5 pg/mg), and TXB2 (1572.8 pg/mg) were all significantly (P less than 0.05) increased in areas of partial ischemia that had not yet developed edema. ODC levels were significantly elevated (3812 pmole/g/hour, P less than 0.05) and increased with time in areas of slightly denser ischemia that showed an intermediate increase in edema, but not the presence of infarction. This is the first demonstration that ODC, the rate-limiting enzyme for polyamine synthesis, is stimulated by cerebral ischemia.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Polyamine and prostaglandin markers in focal cerebral ischemia. 386 30
Mechanisms of vascular hypertrophy induced by hypertension were studied in cultured aortic smooth muscle cells from spontaneously hypertensive rats (SHR) and
stroke
-prone SHR (SHRSP) and compared with those from normotensive Wistar-Kyoto (WKY) rats. Fetal calf serum-stimulated
ornithine decarboxylase
(
ODC
) activity of cultured smooth muscle cells was greater in SHR and SHRSP than in WKY. Beta- but not alpha-adrenergic agonist stimulated
ODC
activity acutely in cultured smooth muscle cells from WKY, and isoprenaline-induced activation was blocked by the beta-blocker, propranolol, and enhanced by the phosphodiesterase inhibitor, 1-methyl-3-isobutylxanthine. These results indicate that cultured vascular smooth muscle cells from SHR and SHRSP are more prone to increase the protein synthesis than those from WKY through the trophic induction of
ODC
activity and that the regulation of
ODC
activity by catecholamines is mediated through beta-agonistic effect in cultured smooth muscle cells.
...
PMID:Studies of hypertension-induced vascular hypertrophy in cultured smooth muscle cells from spontaneously hypertensive rats. 619 73
Since the early development of structural cardiovascular change in spontaneously hypertensive rats (SHR) and
stroke
-prone SHR (SHRSP) indicated the involvement of non-pressure-dependent factors in this process in hypertension, smooth muscle cells (SMC) from the aorta of SHR, SHRSP, and normotensive Wistar-Kyoto rats (WKY) were investigated under tissue culture conditions free from blood pressure and humoral factors in vivo. By the observation of such factors as growth rate and DNA or protein synthesis vascular SMC from these rats with genetic hypertension were proved to have intrinsically greater growth activity independently of blood pressure. Although serum from SHR and SHRSP had no specific stimulative effect on SMC growth, circulating epinephrine may accelerate cardiovascular structural changes because isoproterenol added to the culture media enhanced
ornithine decarboxylase
(
ODC
) activity. Moreover, SMC from SHR and SHRSP showed greater thymidine incorporation than those from WKY even in response to lower extracellular Na+ concentration. Local nutritional conditions of SMC, which were proved to have a great effect on the morphology and structure of cultured SMC, may be a basic determinant of the development of hypertension-induced structural vascular changes or lesions.
...
PMID:Humoral trophic influence on cardiovascular structural changes in hypertension. 624 Apr 50
1. The basic mechanism underlying the structural vascular changes occurring in hypertension was studied in cultured aortic smooth muscle cells (SMC) obtained by an explant method from spontaneously hypertensive rats (SHR) and
stroke
-prone SHR (SHRSP) and compared with that in normotensive Wistar--Kyoto (WKY) rats. 2. The growth rate of SMC from SHR and SHRSP at the age of 2.5--11 months was greater than that of SMC from WKY rats even after repeated passages. 3. [3H]Thymidine and [14C]leucine incorporation, and
ornithine decarboxylase
(
ODC
) activity of SMC were increased in SHR and SHRSP in comparison with WKY rats. 4. The application of isoprenaline but not noradrenaline to the culture media increased
ODC
activity acutely in SMC from WKY rats and this increase was blocked by propranolol. 5. These results indicate that SMC from SHR and SHRSP are more prone to proliferate than those from WKY rats and that a beta-adrenergic neurohumoral mechanism accelerates SMC growth independently of blood pressure.
...
PMID:Mechanisms of structural vascular changes in genetic hypertension: analyses on cultured vascular smooth muscle cells from spontaneously hypertensive rats. 718 65
Brain polyamines have been associated with posttraumatic vasogenic edema and blood-brain barrier (BBB) breakdown seen in some models of brain injury. We hypothesized that the inhibition of the enzyme responsible for polyamine production with the decarboxylase difluoromethylornithine (DFMO) may decrease BBB breakdown after a focal brain ischemic
stroke
. Thirty-two cats underwent 8 hours of middle cerebral artery occlusion and one of four treatments: sham operation (Sham), ischemia (Isc), ischemia/DFMO (Isc/DF), and ischemia/DFMO/putrescine (Isc/DF/PU). The regional brain specific gravity and the volume of Evans blue (EB) extravasation were measured at the time of death. The groups were monitored for temperature, heart rate, blood pressure, and arterial blood gases, and the values did not differ outside normal physiological ranges. EB results were expressed as the percentage of the hemisphere stained and showed the following: Sham, 2.23%; Isc, 32.8%; Isc/DF, 5.6%; Isc/DF/PU, 36.3%. As a measure of BBB, ischemia increased EB staining; DFMO pretreatment decreased the amount of EB staining to control levels; and the polyamine putrescine abolished the protective effect of DFMO (all significant at P = 0.05). DFMO pretreatment also resulted in a significant (P = 0.05) return to control values for specific gravity in the EB-stained regions (1.0328) of ischemic animals. This effect was present primarily in the white matter. Treatment with DFMO, an
ornithine decarboxylase
inhibitor, significantly decreased postischemic BBB breakdown and vasogenic edema in this model.
...
PMID:Difluoromethylornithine decreases postischemic brain edema and blood-brain barrier breakdown. 826 88
Ornithine decarboxylase
(
ODC
), a key enzyme in polyamine biosynthesis, is induced in ischemic tissue and may mediate vasogenic edema and delayed neuronal death. We determined the effects of alpha-difluoromethylornithine (DFMO), a specific inhibitor of
ODC
, on infarct size and
ODC
activity in a rat model of transient focal ischemia. DFMO blocked the ischemia-induced increase in
ODC
and significantly reduced infarct volumes by 57-45%, depending upon the treatment regimen. These studies suggest that polyamine metabolism plays a role in the development of cerebral infarction after focal ischemia and that DFMO may be useful in limiting injury after a
stroke
.
...
PMID:DFMO reduces cortical infarct volume after middle cerebral artery occlusion in the rat. 840 13
1
2
Next >>